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Review
During the 1960s, hospital admission rates in
England and Wales for childhood asthma
steadily increased. This trend continued into
the 1980s and began a steady decline in the
1990s, with no apparent explanation for this
trend (van Schayck and Smit 2005). By
2000, annual admissions for asthma in
England and Wales were 48 and 16 per
10,000 in children younger than 5 and those
5–14 years, respectively (National Statistics
2007). In 2004, asthma caused 1,266 deaths
in England and Wales, 38 of which were chil-
dren younger than 14 years, accounting for
2.9% of all deaths of 1- to 14-year-olds
(National Statistics 2007). In the United
States, the prevalence of self-reported asthma
reached a peak of 60.5 per 1,000 population
in children 0–4 years of age and 82.5 in chil-
dren 5–14 years of age in 1995 and has since
declined (Mannino et al. 2002).
A known risk factor for the development
of atopic asthma is exposure and sensitisation
to the house dust mite Dermatophagoides
pteronyssinus. A meta-analysis of measures to
reduce house dust mite exposure concluded
there was no evidence to suggest implementing
avoidance measures (Gøtzsche et al. 1998).
However, the review did not include any
prospective studies examining potential avoid-
ance of atopic disease development. If the eti-
ology of asthma and the role of household
interventions in mitigating the disease can be
more fully understood, there is an increased
likelihood that asthma can be treated more
appropriately and perhaps prevented.
Our primary objective was to assess
whether any household intervention aimed at
ameliorating exposure to house dust mite could
reduce the incidence of asthma in high-risk
children or reduce the severity of asthma in
individuals already diagnosed with the disease.
Data Sources
Potential studies on household intervention
and asthma were identified from a series of
electronic searches. Databases searched were the
Cochrane Central Register of Controlled Trials
(CENTRAL; http://www.mrw.interscience.
wiley.com/cochrane/cochrane_clcentral_
articles_fs.html), MEDLINE (http://gateway.
ovid.com/), and EMBASE (http://www.
embase.com/). Searches were conducted in
week 2 of 2007, and no date or language
restriction was placed on the literature search.
The databases were searched with the follow-
ing criteria: “hypersensitivity” [MeSH term]
OR “hypersensitivity” [text word] OR
“asthma” [MeSH term] OR “asthma” [text
word] OR “eczema” [MeSH term] OR
“eczema” [text word] OR “dermatitis atopic”
[MeSH term] OR “dermatitis atopic” [text
word] OR “allergy” [MeSH term] OR
“allergy” [text word] AND “household”
[MeSH term] OR “hygiene” [text word] OR
“hygiene” [MeSH term] OR “hygiene” [text
word] OR “animal domestic” [MeSH term]
OR “domestic animal” [text word] OR “pets”
[text word] OR “dust” AND “randomized
controlled trials” [MeSH term] OR “random-
ized controlled trial” [text word] OR “random-
ized controlled trial” [text word] OR “RCT”
[text word].
In addition, when close to completion, we
performed a further search of articles search-
ing only for recent articles and using the terms
“dust” and “asthma” for 2006 onward. Also,
the Institute of Scientific Information data-
base of global conference proceedings (http://
portal.isiknowledge.com/) was searched for
abstracts of relevant presentations at scientiﬁc
conferences for 2002 and later that had not
yet been published as full articles.
Abstracts for all the publications identiﬁed
by the search were reviewed and assessed for
suitability for inclusion by two authors of the
present article. Where disagreement occurred,
a third assessor contributed to the ﬁnal deci-
sion. Full copies of all suitable studies were
obtained, and a further decision was made as
to whether they fulfilled the search criteria.
During the entire selection process, none of
the authors were blinded to the source of the
publication, its authors, or any other detail.
Data Extraction
Types of studies. All randomized trials that
compared any household intervention to a con-
trol group with placebo (where practical) or no
intervention were considered for this review.
Types of participants. As atopic disease
affects adults and children, no restriction was
based on age, hence studies that had their
own age restriction were considered. It was
anticipated that there would be a mixture of
studies recruiting in the antenatal period
prospectively examining the development of
atopic disease and those that recruited known
atopic individuals.
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OBJECTIVES: We assessed whether any household dust reduction intervention has the effect of
increasing or decreasing the development or severity of atopic disease.
DATA SOURCES: Electronic searches on household intervention and atopic disease were conducted in
January 2007 in EMBASE, MEDLINE, and the Cochrane Central Register of Controlled Trials.
No date or language restriction was placed on the literature search.
DATA EXTRACTION: We included randomized controlled trials comparing asthma outcomes in a
household intervention group with either placebo intervention or no intervention.
DATA SYSNTHESIS: Fourteen studies met the inclusion criteria. Eight recruited antenatally and meas-
ured development of atopic disease. Six recruited known atopic individuals and measured disease
status change. Meta-analyses on the prevention studies found that the interventions made no differ-
ence to the onset of wheeze but made a signiﬁcant reduction in physician-diagnosed asthma. Meta-
analysis of lung function outcomes indicated no improvement due to the interventions but found a
reduction in symptom days. Qualitatively, health care was used less in those receiving interventions.
However, in one study that compared intervention, placebo, and control arms, the reduction in
heath care use was similar in the placebo and intervention arms.
CONCLUSIONS: This review suggests that there is not sufﬁcient evidence to suggest implementing
hygiene measures in an attempt to improve outcomes in existing atopic disease, but interventions
from birth in those at high risk of atopy are useful in preventing diagnosed asthma but not
parental-reported wheeze.
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to be atopic needed to have either a clinical
diagnosis of asthma or positive skin prick test
to a known trigger allergen. Prospective stud-
ies with antenatal recruitment had a first-
degree relative with a clinical diagnosis of
atopic disease or atopic disease conﬁrmed on
skin-prick testing. Studies would still be con-
sidered if they compared these individuals
with lower-risk individuals, as long as there
was a direct comparison between two groups
of high-risk individuals receiving or not
receiving a household intervention.
Types of intervention. Inevitably, there
would be a wide range of household interven-
tions. Those considered for review were the
following:
• Provision of allergen-impermeable bedding
compared with no change in care or with
placebo.
• Provision of household cleaning product or
equipment (for example, high-efficiency
vacuum cleaners) compared with no change
or with the provision of placebo/alternative
products.
• Education programs about allergen reduc-
tion measures compared with no additional
educational input.
• Changes to home environment (for exam-
ple, mold reduction and repairs to heating
systems) compared with no change in home
environment or with education only with
no physical help.
Types of outcome measures. Any outcome
measure referring to the development, exacer-
bation, or severity of atopy was considered.
We anticipated that many studies examining
allergen reduction would measure allergen
levels as a primary outcome. As this was not
the aim of the present review, such studies
would be included only if they also provided
a measurement of atopic disease indicators.
Types of outcome measures indicating the
development of atopy were as follows: a) pres-
ence of wheeze (noted by parent or general
practioner); b) diagnosis of asthma; c) pre-
scribed asthma medication; and d) positive
skin test to an aeroallergen.
Below are the types of outcome measures
indicating the severity of atopy in studies in
which participants were known to be atopic:
a) severity of eczema; number of acute hospital/
clinic visits for asthma; b) combined asthma
outcome [a measure based on treatment
requirement and bronchial hyperreactivity to
histamine used by Francis et al. (2003)];
c) lung function; d) peak flow; and e) diary
days with chest tightness.
Analysis. We methodologically assessed
the studies meeting the inclusion criteria using
a validated five-point scoring system (Jadad
et al. 1996). This tool assesses quality of ran-
domized controlled trials on the basis of the
reported quality of randomization, blinding,
and adequate descriptions of subject with-
drawals and dropouts. The score is calculated
according to whether the study is randomized
and double blinded. Additional points are
given based on the description of withdrawals
and adequacy of description of the randomiza-
tion and blindness. Data were extracted using
a standard form adapted from a sample form
provided by the Berkeley Systematic Reviews
Group (2007). The main data extracted were
duration of study, study size, nature of inter-
vention, and outcome measures. The data
were then entered into a Microsoft Excel
(Microsoft Corp., Redmond, WA, USA)
spreadsheet for analysis .
Meta-analysis was done using StatsDirect
(StatsDirect 2007). For continuous outcomes
such as peak flow or days of symptoms, an
effects-size meta-analysis was performed. For
dichotomous outcomes relative risk meta-
analysis is reported. Given the diversity of
interventions included, random-effects mod-
els were used. In addition, data were tested
for bias and study heterogeneity.
Data Synthesis
Description of studies. The initial electronic
search yielded 248 references. Duplicates (stud-
ies found by more than one database) were
excluded and the remaining abstracts screened
by C.R. and A.S. After the screening, 33 refer-
ences were selected to be more thoroughly
examined for potential inclusion. Eleven of
these met the inclusion criteria for the present
review. Three additional recent articles were
identiﬁed using the search, bringing the total to
14 to meet the inclusion criteria.
The characteristics of the studies meeting
the criteria for inclusion, including types of
participants, duration of the study, and a
summary of the intervention used are pre-
sented in Table 1.
One meeting abstract was identiﬁed that
investigated the impact on symptoms of
asthma, but this was a small study of only 44
children with asthma and no controls; thus,
this was not analyzed further (Brugge et al.
2006).
Methodological quality. The quality of
reporting in the studies included was variable,
with included studies all achieving either 2 or
3 with a mean Jadad score of 2.4. In some
cases the study design was prohibitive of a
blinding process, thus preventing the studies
from reaching a score > 3 based on the Jadad
criteria.
The population sizes in the studies identi-
ﬁed ranged from 30 to 937 and the duration
of follow-up ranged from 6 months to
7 years. Most studies did not provide placebo
interventions for the control group and left
the group with no change in their care. Three
studies used placebo, two provided a nominal
part of the intervention and one provided the
same information and equipment after
completion of the study period.
Separate analyses were performed of those
studies measuring prevention and those
assessing improvement.
Prevention of asthma. Eight studies con-
sidered interventions to prevent asthma
(Arshad et al. 2007; Becker et al. 2004; Chan-
Yeung et al. 2000, 2005; Corver et al. 2006;
Custovic et al. 2001; Marks et al. 2006;
Schönberger et al. 2005). Three articles repre-
sented repeat analyses of the same cohort;
thus, only the most recent report was
included in the analysis (Becker et al. 2004;
Chan-Yeung et al. 2000, 2005).
Five of the studies had comparable inter-
ventions, providing education about allergen
exposure reduction as well as allergen reduc-
tion equipment (Arshad et al. 2007; Chan-
Yeung et al. 2005; Corver et al. 2006;
Custovic et al. 2001; Marks et al. 2006). The
sixth did not implement any physical changes
but provided a comprehensive education pro-
gram on how to reduce newborns’ exposure
to allergens (Schönberger et al. 2005).
All six studies were analyzed for two out-
come measures: physician-diagnosed asthma
and parent-reported wheeze. From the data
available in this outcome measure, a relative
risk meta-analysis was performed. The forest
plots are shown in Figures 1 and 2. All five
studies that reported on physician-diagnosed
asthma demonstrated a reduction in diag-
nosed asthma in the intervention arm by the
end of the study period, although in only one
was this statistically signiﬁcant. Nevertheless,
the pooled estimate showed a significant
reduction [relative risk (RR) = 0.79; 95%
confidence interval (CI) 0.66–0.94; p =
0.0093, fixed-effects model). There was no
evidence of bias (0.091), and Cochran’s Q
was not statistically significant (p = 0.626),
supporting the use of the ﬁxed-effects model.
For the ﬁve studies that reported on par-
ent-reported wheeze, only one study showed a
signiﬁcant reduction in the intervention arm
and two showed an actual increase. The com-
bined effect of the interventions did not show
a significant impact on parent-reported
wheeze (RR = 0.95; 95% CI 0.78–1.15; p =
0.616). However, both bias (p = 0.005) and
Cochran’s Q (p = 005) were statistically sig-
niﬁcant, indicating possible bias in the results
and heterogeneity in the study outcomes.
Improvement in already-diagnosed
asthma. Six of the identified studies were
concerned with estimating the impact of
house dust reduction on the severity of
asthma (Carter et al. 2001; Francis et al.
2003; Kercsmar et al. 2006; Luczynska et al.
2003; Morgan et al. 2004; Williams et al.
2006). Many different outcome measures
were used in these studies, and often the
analyses presented for these outcome
Macdonald et al.
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Table 1. Randomized control studies of house dust reduction interventions on the prevention or control of asthma.a
Measured
Duration Control Intervention Control group Intervention group prevention or Jadad
Reference Inclusion criteria of study no. no. intervention intervention improvement score
Carter et al. 2001 Present on a database as being 12 months 35 34 No intervention Placebo—allergen-permeable Improvement 2
treated for asthma mattress and pillow covers, ineffective 
roach traps, no instructions
35 Allergen-impermeable mattress and 
pillow covers, roach bait, laundry 
instructions, and instructions about 
cleaning to control dust mites 
Custovic et al. 2001 Pregnancies with either: 12 months 146 No intervention Allergen-impermeable bedding Prevention 2
a) both parents atopic, positive to 145 covers ﬁtted to parental bed, laundry 
skin-prick test (high risk) and instructions, and high-ﬁltration vacuum
no pets; b) both parents atopic,  cleaner, damp dusting.
positive to skin-prick test (high risk)  161 Vinyl cushion ﬂooring ﬁtted in child’s
and pets; c) both parents skin-prick bedroom, custom-made crib and cot
test negative; no family history 168 mattresses, hot-washable soft toy,
of atopy (low risk) washing instructions
Francis et al. 2003 Age between 18–65 years with a 12 months 15 15 HEPA vacuum Honeywell Envirocare HEPA cleaners in Improvement 2
diagnosis of asthma and living cleaners alone, living room and bedroom and Dyson
with cat or dog vacuuming minutes HEPA vacuum cleaners vacuuming
2× per week minutes 2× per week
Luczynska Age 18–54 years with asthma  12 months 25 30 Sham allergen- Allergen-proof bed covers Improvement 2
et al. 2003 diagnosis, taking inhaled steroids,  proof bed covers
sensitive to house dust mite
Morgan et al.  Age 5–11 years with an asthma 12 months 468 469 No intervention Providing child’s caretaker with Improvement 3
2004 diagnosis, asthma-related knowledge, skills, motivation,
hospital admission and positive equipment to perform environmental
skin-prick test remediation with 5–7 home visits
Schönberger Asthma in at least mother, father, 2 years 234 242 No intervention Instruction from nurses on reducing Prevention 3
et al. 2005 or siblings of unborn child mite allergens, pet allergens, food 
allergens, etc.
Kercsmar et al.  Age 2–17 years with symptomatic 12 months 33 29 Information Home remediation performed 4–5 Improvement 3
2006 asthma for at least 3 months given improving months after study began, including
and hospital visit with asthma home indoor cleaning, repairs, air conditioning, etc.
in past year air quality
Chan-Yeung High risk for atopy—at least 1 12 months 267 278 No intervention Mattress assessment, laundry Prevention 2
et al. 2000 ﬁrst-degree relative with asthma instructions, benzyl benzoate application
or 2 second-degree with other to carpets and furniture, counseled about
allergic diseases identiﬁed in pets, smoking cessation
third trimester
Becker et al. 2004 High risk for atopy—at least 1 2 years 267 278 No intervention Mattress assessment, laundry Prevention 2
ﬁrst-degree relative with asthma instructions, benzyl benzoate application
or 2 second-degree with other to carpets and furniture, counseled 
allergic diseases identiﬁed in about pets, smoking cessation
third trimester
Chan-Yeung High risk for atopy—at least 1 7 years 266 279 No intervention Mattress assessment, laundry Prevention 2
et al. 2005 ﬁrst-degree relative with asthma instructions, benzyl benzoate application
or 2 second-degree with other to carpets and furniture, counseled about
allergic diseases identiﬁed in pets, smoking cessation
third trimester
Williams et al. 2006 English-speaking 5- to 12-year  12 months 77 84 Same as Information and equipment to reduce Improvement 3
olds with asthma exacerbation intervention allergen exposure: mattress encasing,
presenting to ED living within group, after the laundry instructions, hydramethylnon
the “Atlanta Empowerment study period gel, smoking advice, professional cleaning
Zone” (high level of poverty)
Marks et al. 2006 Prenatally identiﬁed high-risk 5 years 308 308 Advice about Impermeable bedding covering, laundry Prevention 2
individuals with at least  allergen reduction. instruction, advice. Provided canola-based
1 parent or sibling who had  Provided poly- oils and spreads and capsules containing
asthma or wheezing unsaturated oils ω-3 fatty acids
and spreads and
capsules low in
ω-3 fatty acids
Arshad et al. 2007 Prenatally identiﬁed high-risk 8 years 62 58 No intervention Elimination of dairy, ﬁsh, wheat, nuts, Prevention 2
individuals (at least 2 family soya from diet, impermeable bedding
members with allergic disease) covers, carpet, and upholstery treatment
Corver et al. 2006 Prenatally identiﬁed high risk 4 years 394 416 Placebo bedding Allergen-impermeable covers Prevention 2
individuals (allergic mother) covers
472 No intervention
Abbreviations: ED, emergency department; HEPA, high-efﬁciency particulate air.
aArticles by Chan-Yeung et al. (2000, 2005) and Becker et al. (2004), were analyses of the same cohort. Only the most recent articles were included in analyses. Macdonald et al.
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measures differed. Two outcome measures
were used for meta-analysis. Three studies
reported some form of a result of lung func-
tion such as FEV1 (forced expiratory volume
in 1 sec) or peak flow (Francis et al. 2003;
Luczynska et al. 2003; Morgan et al. 2004).
For these three studies we conducted an
effects-size meta-analysis (Figure 3). The
pooled estimates of effects size did not show
any significant impact of the intervention
(–0.084; 95% CI, 0.452–0.284).
There was sufﬁcient information on only
two studies to perform a meta-analysis for
days with symptoms (Figure 4) (Luczynska
et al. 2003; Morgan et al. 2004). The meta-
analysis showed a significant reduction in
days ill in the intervention group (–0.361;
95% CI, –0.590 to –0.131).
Several studies reported outcome meas-
ures for unplanned hospital or clinic visits;
unfortunately the studies did not analyze the
data similarly nor did they present their
results in a form sufficient to allow a meta-
analysis. However, one study worth mention-
ing used control, placebo, and intervention
arms (Carter et al. 2001). The study identi-
ﬁed a signiﬁcant decrease in clinic attendances
in the intervention and placebo arms but not
in the control arms, suggesting that there is a
strong placebo effect on subjective measures
of asthma severity.
Conclusions
One major difficulty in conducting this
review and meta-analysis was the wide range
of different outcome measures used and the
ways in which such measures were analyzed
and presented. This made extraction of data
particularly difficult, especially for those
studies investigating dust reduction interven-
tions as a means of reducing the severity of
asthma. It is necessary that there be standard-
ization in reporting the results of studies of
interventions aimed at reducing the severity
of symptoms of asthma. A further issue was
the relatively low Jadad score of only 2.4,
which reflects the lack of blinding in almost
all studies.
The results of the present meta-analysis
suggest a significant reduction in physician-
diagnosed asthma as a result of interventions
to reduce exposure to house dust (RR = 0.74;
95% CI, 0.58–0.95). However, there was no
significant effect on parent-reported wheeze
(RR = 0.95; 95% CI, 0.78–1.15). This may
suggest that reduced exposure to house dust
prevents the more severe form of asthma but
not the more common and milder forms.
This is consistent with the observation that
the majority of physician-diagnosed asthma
cases in children are atopic, whereas many
cases of parent-reported wheeze are often not
atopic (Kaditis et al. 2007; Morais-Almeida
et al. 2007). Indeed parents frequently err in
reporting the presence of wheeze, both erro-
neously reporting its presence when it is not
there and not recognizing wheeze when it is
there (Cane et al. 2000; Cane and McKenzie
2001). Nevertheless, a 26% reduction in
physician-diagnosed asthma would be a
worthwhile beneﬁt.
The results of the analyses on disease
severity reduction were conflicting. The
results of lung function did not show
improvement (–0.084; 95% CI, –0.452 to
0.284), whereas the number of days ill, a
more subjective estimate of severity, was
reduced (–0.361; 95% CI, –0.590 to –0.131).
Together, the ﬁndings of this review and the
results of the meta-analysis give an uncertain
and mixed estimate of the value of interven-
tions aimed at reducing house dust on sever-
ity of asthma. The finding of a reduction in
disease severity as measured by unplanned
hospital and clinic attendances in both inter-
vention and placebo arms in one study raises
concerns that much of the impact of house
dust reduction interventions may have a psy-
chological rather than a direct effect (Carter
et al. 2001). This is particularly the case given
the lack of blinding in most studies.
A further explanation for the mixed
results may be that the efﬁciency of the inter-
ventions at reducing exposure to antigens
from house dust mites varied among studies.
There is evidence from some studies that dust
reduction measures may not be particularly
effective (Carter et al. 2001), particularly for
children living in poorer areas (Carter et al.
2001). However, Schönberger et al. (2004)
assessed compliance with dust reduction pro-
cedures and found good compliance with
antimite encasing advice but not with more
demanding actions such as the use of smooth
ﬂoor coverings in living room and nursery.
In conclusion, the evidence in favor of
interventions aimed at reducing exposure to
house dust for the prevention of physician-
diagnosed asthma in high-risk children is
strong. In this regard we consider the evi-
dence to be stronger than the conclusions of
other reviews (Semic Jusufagic et al. 2006).
However, the impact of interventions appears
not to affect parent-reported wheeze.
The evidence for house dust reduction in
controlling the symptoms of asthma is cur-
rently weak, and it is not yet possible to
advise on the general feasibility of this strategy
in asthmatic children. One problem in deter-
mining the value of this intervention was the
different outcome measure used and the way
results were presented, which prevented a for-
mal meta-analysis. Agreement is needed on
appropriate standards for the conduct and
analysis of future trials of environmental
interventions to control the clinical severity
of asthma.
Figure 3. Effect of house dust reduction interventions
on lung function. DL (DerSimonian-Laird) pooled
effect size = –0.084057; 95% CI, –0.452474 to –0.28436.
Error bars indicate 95% CIs.
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Francis et al. 2003
Effect-size meta-analysis plot (random effects)
–1 0 1
Morgan et al. 2004
Luczynska et al. 2003
Figure 4. Effect of house dust reduction interven-
tions on days ill with asthma. DL (DerSimonian-
Laird) pooled effect size = –0.360796; 95% CI,
–0.590095 to –0.131497. Error bars indicate
95% CIs.
–2.0
Effect-size meta-analysis plot [random effects]
–1.5 0
Morgan et al. 2004
Luczynska et al. 2003
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Figure 1. Meta-analysis [RR (95% CI)] of interven-
tions to prevent physician-diagnosed asthma. Error
bars indicate 95% CIs.
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Figure 2. Meta-analysis [RR (95% CI)] of interven-
tions to prevent parent-reported wheeze. Error
bars indicate 95% CIs.
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CORRECTION
The last name of the ﬁrst author has been
changed from Russell in the original manu-
script published online to Macdonald in
the ﬁnal version.